Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot phase 4 study of adjunctive norfloxacin with standard antibiotic therapy in spontaneous bacterial peritonitis
2008-001367-11Phase 4Active
- Sponsor
- CIBEREHD
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of norfloxacin, cefotaxime and ceftriaxone in primary peritonitis (2 arms), sponsored by CIBEREHD. Primary endpoint: Presence of bacterial DNA in serum. Started Jun 2008; status: active.
02
Drugs
norfloxacincefotaximeceftriaxone
03
Conditions
primary peritonitis
Beyond the preview
Go deeper on 2008-001367-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001367-11.